site logo
ARRS InPractice
  • Latest Issue
  • Contact Us
Homepage > Articles > Epilepsy and Dementia—A New Utility

Epilepsy and Dementia—A New Utility

brainip

Published January 21, 2022

avatar

Allison M. Grayev

Associate Professor of Radiology, Neuroradiology Section Director, Spine Imaging
Associate Residency Program Director
University of Wisconsin School of Medicine and Public Health

    avatar

    Chadwick L. Wright

    Assistant Professor, Department of Radiology
    Division of Molecular Imaging and Nuclear Medicine
    Wright Center of Innovation in Biomedical Imaging
    The Ohio State University Wexner Medical Center

      Although these two populations—epilepsy patients and dementia patients—may seem very different at first glance, they share a number of important characteristics. Their clinical presentation is often myriad and varied, and early diagnosis leads to better long-term outcomes and more efficient health care utilization. Radiology is often critical for the proper diagnosis and management of these patients. To best utilize imaging resources and interpret studies, we will explore anatomic and functional considerations in these disease processes during our Sunday Featured Session, “Multimodality Approach to Epilepsy and Dementia,” at the 2022 ARRS Annual Meeting in New Orleans, LA.

      In 2020, the estimated health care costs for Alzheimer treatment alone was estimated at $305 billion, not including other causes of dementia. It is even more difficult to quantify the monetary cost of epilepsy treatment, much less the cost of quality of life issues. Often times a combined approach with multiple imaging modalities is needed to accurately diagnosis these conditions—but where do we start, and how do we integrate the information?

      Higher-resolution anatomic imaging, including diffusion tensor imaging, holds promise in both conditions, but it often serves as an entry point into the diagnostic algorithm. Artificial intelligence has gained traction in automatic segmentation of brain parenchyma, theoretically allowing a more precise localization of volume loss, which can be seen in selective areas in both conditions. This may allow stratification of patients in a community setting, before potential referral to a tertiary center for further evaluation.

      Having a working understanding of available molecular imaging agents is also critical for optimizing patient evaluation. Although fluorine-18 fluorodeoxyglucose (18FDG) is in common use for oncologic PET, there is applicability in neurodegenerative imaging, potentially allowing the identification of relatively hypometabolic areas prior to the development of anatomic changes. Additional neurodegenerative PET imaging agents target amyloid and tau protein deposition. Brain perfusion nuclear medicine imaging, as well as 18FDG-PET, can also be helpful in the assessment and localization of epileptogenic foci.

      https://arrs.org/ARRSLIVE/Education/OnlineCourses/OC_MAED22.aspx

      The goal of our “Multimodality Approach to Epilepsy and Dementia” session is to explore a different utility of anatomic and molecular imaging in the evaluation of patients with these challenging neurological disorders, allowing radiologists to better understand potential imaging algorithms and advanced diagnostic tests.


      The opinions expressed in InPractice magazine are those of the author(s); they do not necessarily reflect the viewpoint or position of the editors, reviewers, or publisher.

      Related

      Previous StoryThriving in a Multigenerational Workforce
      Next StoryPractical Implementation of a CT Colonography Service

      ARRS

      Contact InPractice
      Meetings
      Articles with Credit
      Books / Books with Credit
      Online Courses
      Web Lectures

      AJR

      AJR Journal
      AJR Articles with Credit
      Subscribe to AJR

      ARRS Membership

      Benefits
      Join / Renew
      Volunteer Opportunities
      In-Training Radiologists
      Senior Radiologists

      Scholarships

      Donate Now
      Roentgen Fund®
      Fellowships / Awards
      Making a Difference

      The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians. ARRS has been granted Deemed Status by the American Board of Radiology (ABR). Copyright ©, American Roentgen Ray Society, ARRS, All Rights Reserved.